Patient’s Perception on MDR and XDR Tuberculosis in a Teaching Hospital

Fazlu Rehman, N Ravindra, A Srinivasa Rao, Ashfaq Hasan, M.A Raoof

Abstract


Tuberculosis (TB) is an infectious disease which is transmitted by air. This disease damages the lungs and other organs in the human body. It is still one of the leading causes of morbidity and mortality despite the fact that it can be cured with adequate treatment. The emergence of multidrug resistant tuberculosis (MDR-TB) or extensively drug resistant (XDR-TB) is one of the challenges in our effort to control the disease complications. The aim of the study was to assess the Patient’s Perception on emergence of MDR & XDR-Tuberculosis in the Pulmonology Department of teaching Hospital

Keywords


patient’s perception; multidrug resistant; tuberculosis; treatment; prevention; control;

Full Text:

PDF

References


B Muller, EM Streicher, KGP Hoek et al (2011). inhA promoter mutations: a gateway to extensively drug-resistant tuberculosis in South Africa. International Journal of Tuberculosis and Lung Disease. 15(3):344–351.

B Muller, S Borrell, G Rose, and S Gagneux (2013). The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis. Trends in Genetics. 29(3):160–169.

CN Paramasiva, K Bhaskaran, P Venkataraman, V Chandrasekaran, et al (2000). Surveillance of drug resistance in tuberculosis in the state of Tamil Nadu. Indian Journal of Tuberculosis. 47:27–33.

D Calver, AA Falmer, M Murray et al (2010). Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa. Emerging Infectious Diseases. 16(2):264–271.

DS Abebe, G Bjune, G Ameni, D Biffa, et al (2011). Prevalence of pulmonary tuberculosis and associated risk factors in Eastern Ethiopian prisons. The International Journal of Tuberculosis and Lung Disease. 15(5):668–673.

EM Streicher, B Muller, V Chihota et al (2012). Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa. Infection, Genetics and Evolution. 12(4):686–694.

GD van der Spuy, RM Warren, M Richardson, N Beyers, et al (2003). Use of genetic distance as a measure of ongoing transmission of Mycobacterium tuberculosis. Journal of Clinical Microbiology. 41(12):5640–5644.

I Vitol, J Driscoll, B Kreiswirth, N Kurepina, and KP Bennett (2006). Identifying Mycobacterium tuberculosis complex strain families using spoligotypes. Infection, Genetics and Evolution. .6(6):491–504.

JA Caminero, G Sotgiu, A Zumla and GB Migliori (2010). Best drug treatment for multidrug-resistant and extensively drugresistant tuberculosis, The Lancet Infectious Diseases. 10(9):621–629.

J Rawat, G Sindhwani and R.Dua (2009). Five-year trend of acquired antitubercular drug resistance in patients attending a tertiary care hospital at Dehradun (Uttarakhand). Lung India. 26(4):106–108.

M Goyal, NA Saunders, and JD van Embden (1997). Differentiation of Mycobacterium tuberculosis isolates by spoligotyping and IS6110 restriction fragment length polymorphism. Journal of Clinical Microbiology. 35(3):647–651.

M Klopper, RM Warren, C Hayes et al (2013). Emergence and spread of extensively and totally drug-resistant tuberculosis, South Africa. Emerging Infectious Diseases. 19(3):449–455.

NK Jain, KK Chopra and G Prasad (1992). Initial and acquired Isoniazid and Rifampicin resistance to M. tuberculosis and its implications for treatment. Indian Journal of Tuberculosis, 39(2):121–124.

NR Gandhi, P Nunn, K Dheda (2010). Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. The Lancet. 6736:1–14.

SD Lawn and R Wilkinson (2006). Extensively drug resistant Tuberculosis. British Medical Journal. 333(7568):559–560.

S Sethi, A Mewara, SK Dhatwalia et al (2013). Prevalence of multidrug resistance in Mycobacterium tuberculosis isolates from HIV seropositive and seronegative patients with pulmonary Tuberculosis in north India. BioMed Central Infectious Disease. 13(137).

SS Trivedi and SG Desai (1988). Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India. Tubercle. 69(1):37–42.

S Verver, RM Warren, Z Munch et al (2004). Proportion of tuberculosis transmission that takes place in households in a high-incidence area. TheLancet, 363(9404):212–214.

S Swaminathan and B Rekha (2010). Pediatric tuberculosis: global overview and challenges. Clinical Infectious Diseases. 50(3):S184–S194.

VG Kumar, T.A Urs and RR Ranganath (2011). MPT 64Antigen detection for rapid confirmation of M.tuberculosis isolates. BMC Research Notes. 4(79).

World Health Organization (2010). Multidrug and Extensively Drug- Resistant TB (M/XDR-TB): Global Report on Surveillance and Response, World Health Organization, Geneva, Switzerland.




DOI: http://dx.doi.org/10.21477/ijapsr.v2i3.8160

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Creative Commons License
International Journal of Applied Pharmaceutical Sciences and Research by Sierra Journals is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Based on a work at http://www.sierrajournals.com/direct/index.php/IJAPSR/issue/archive.